Table 7.
Full Population | 10% |
By Stage | |
I and II | 5–10% |
III | 15% |
IV | 40–60% |
Other subtypes | |
Acral or Mucosal | 10–30% |
Uveal | 2–6% |
Mutation Status | |
BRAF mutant | 20–25% |
KRAS mutant | 20–25% |
Full Population | 10% |
By Stage | |
I and II | 5–10% |
III | 15% |
IV | 40–60% |
Other subtypes | |
Acral or Mucosal | 10–30% |
Uveal | 2–6% |
Mutation Status | |
BRAF mutant | 20–25% |
KRAS mutant | 20–25% |